3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Phase 2
1
Status
Completed
7
Withdrawn
3
Terminated
2
Recruiting
2
Not yet recruiting
2
Unknown
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
1
Breast
1
Conditions
Gastroparesis
1
Esophageal Motility Disorders
1
Esophageal Diseases
1
Esophageal Achalasia
1
Breast Neoplasms
1
Agnosia
1
Interventions
Specimen Handling
334
Magnetic Resonance Spectroscopy
334
Radiotherapy
315
Cyclophosphamide
295
pembrolizumab
281
Cisplatin
267
Carboplatin
245
Drug Therapy
237
Blood Specimen Collection
233
Biopsy
204
Bevacizumab
186
Gemcitabine
178
venetoclax
172
Radiosurgery
169
Capecitabine
164
Oxaliplatin
163
fludarabine
161
Nivolumab
156
Paclitaxel
155
Standard of Care
136
Surveys and Questionnaires
130
Surgical Procedures, Operative
130
Dexamethasone
126
Fluorouracil
124
Docetaxel
113
tislelizumab
110
Rituximab
110
Cytarabine
104
Azacitidine
101
atezolizumab
100
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
OTHER
×
Botulinum Toxins, Type A
×
Clear all
NCT06807164
2026-03-27
SerCaBot
Centre Oscar Lambret
Phase 2
Recruiting
123 enrolled
NCT06721520
2026-02-25
EMPTY
The Cleveland Clinic
Phase 2/3
Recruiting
170 enrolled